Homologous recombination repair deficiency (HRD) testing in newly diagnosed advanced-stage epithelial ovarian cancer: A Belgian expert opinion

Ovarian cancer (OC) has a poor prognosis as most patients present with non-specific symptoms and the disease is mostly diagnosed at advanced stages. Approximately 90% of cases are classified as epithelial OC (EOC), a category comprising histologically and molecularly distinct tumours. Identifying re...

Descripción completa

Detalles Bibliográficos
Autores principales: Vergote, I, Denys, H, Altintas, S, Kerger, J, Baurain, J-F, Bours, V, Henry, S, Van de Vijver, K, Lambrechts, D, Gennigens, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Universa Press 2022
Materias:
Opinion and Viewpoint Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191713/
https://www.ncbi.nlm.nih.gov/pubmed/35781107
http://dx.doi.org/10.52054/FVVO.14.2.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191713/
https://www.ncbi.nlm.nih.gov/pubmed/35781107
http://dx.doi.org/10.52054/FVVO.14.2.024

Ejemplares similares